Cantitate/Preț
Produs

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America: The Clinics: Internal Medicine, cartea 37-1

Editat de Harold J. Burstein
en Limba Engleză Hardback – 28 noi 2022
In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more.
Citește tot Restrânge

Din seria The Clinics: Internal Medicine

Preț: 63565 lei

Preț vechi: 66910 lei
-5% Nou

Puncte Express: 953

Preț estimativ în valută:
12164 12623$ 10167£

Carte disponibilă

Livrare economică 22 februarie-08 martie
Livrare express 11-15 februarie pentru 3769 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443181856
ISBN-10: 0443181853
Pagini: 240
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine


Cuprins

Disparities in Breast Cancer Outcomes and How to Resolve Them
Testing for Inherited Susceptibility to Breast Cancer
Breast Cancer Pathology in the Era of Genomics
Breast Cancer Pathology in the Era of Genomics
Role of Ovarian Suppression in Early Premenopausal Breast Cancer
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
Biology and Treatment of HER2-Low Breast Cancer
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer
Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Multidisciplinary Management of Brain Metastasis from Breast Cancer
Systemic Therapy for Hereditary Breast Cancers
Evidence-Based Guidance for Breast Cancer Survivorship